Voyager Therapeutics Inc. | Key People and Executives
G. Andre Turenne
President, Chief Executive Officer & Director
Steven Marc Paul
Director
Glenn F. Pierce
Independent Director
Wendy L. Dixon
Independent Director
Perry A. Karsen
Independent Director
James A. Geraghty
Independent Director
Michael J. Higgins
Independent Director
Steven E. Hyman
Independent Director
G. Andre Turenne
President, Chief Executive Officer & Director
Matthew P. Ottmer
Chief Operating Officer
Allison Dorval
Chief Financial & Accounting Officer
Luis Maranga
Chief Technical Operations Officer
Allen Nunnally
Vice President-Corporate & Business Development
Dinah W. Y. Sah
Chief Scientific Officer
Steven Marc Paul
Director
Matthew S. Osborne
VP-Investor Relations & Corporate Communications
Kathleen Hayes
Vice President-Human Resources
Robert G. Pietrusko
SVP-Regulatory Affairs & Quality Assurance
Glenn F. Pierce
Independent Director
Wendy L. Dixon
Independent Director
Perry A. Karsen
Independent Director
James A. Geraghty
Independent Director
Michael John Higgins
Independent Director
Steven E. Hyman
Independent Director
| Address |
75 Sidney Street
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.voyagertherapeutics.com |
| Updated |
07/08/2019 |
| Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. |
